Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model

Cancer Research

Volumn 57, Issue 16, 1997, Pages 3325-3330

  Foster, Barbara A ^a   Gingrich, Jeffrey R ^a   Kwon, Eugene D ^b   Madias, Christopher ^b   Greenberg, Norman M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; CYTOKERATIN; ONCOPROTEIN; UVOMORULIN; VIRUS LARGE T ANTIGEN; VIRUS T ANTIGEN;

ADENOCARCINOMA; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL TRANSFORMATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; MALE; MALIGNANT TRANSFORMATION; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; SIMIAN VIRUS 40; TRANSGENIC MOUSE;

ADENOCARCINOMA; ANDROGEN-BINDING PROTEIN; ANIMALS; ANTIGENS, VIRAL, TUMOR; CADHERINS; DISEASE PROGRESSION; KERATINS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030860498     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1997. CA Cancer J. Clin., 47: 5-27, 1997.
2. Peehl, D. Human prostatic epithelial and stromal cell lines and strains. Urol. Oncol., 2: 100-101, 1996.
3. Chung, L. W. K. LNCaP human prostate cancer progression model. Urol. Oncol., 2: 126-128, 1996.
4. van Weerden, W. M., and van Steenbrugge, G. J. Human prostate tumor xenografts as representative models for clinical prostate cancer. Urol. Oncol., 2: 122-125, 1996.
5. Bosland, M. C. Chemical and hormonal induction of prostate cancer in animal models. Urol. Oncol., 2: 103-110, 1996.
6. Ho, S., and Lane, K. Sex hormone-induction and dietary modulation of prostatic adenocarcinoma (PA) in animal models. Urol. Oncol., 2: 110-115, 1996.
7. Isaacs, J. T. The R-3327 system of rat prostatic cancers. Urol. Oncol., 2: 115-116, 1996.
8. Thompson, T. C. Mouse prostate reconstitution: an in vivo transgenic gland model system. Urol. Oncol., 2: 117-119, 1996.
9. Greenberg, N. M., DeMayo, F., Finegold, M. J., Medina, D., Tilley, W. D., Aspinall, J. O., Cunha, G. R., Donjacour, A. A., Matusik, R. J., and Rosen, J. M. Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. USA, 92: 3439-3443, 1995.
10. Gingrich, J. R., Barrios, R. J., Morton, R. A., Boyce, B. F., DeMayo, F. J., Finegold, M. J., Angelopoulou, R., Rosen, J. M., and Greenberg, M. M. Metastatic prostate cancer in a transgenic mouse. Cancer Res., 50: 4096-4102, 1996.
11. Prins, G. S., and Birch, L. The developmental pattern of androgen receptor expression in rat prostate lobes is altered after neonatal exposure to estrogen. Endocrinology, 136: 1303-1314, 1995.
12. Li, B., Greenberg, N., Stephens, L., Meyn, R., Medina, D., and Rosen, J. Preferential overexpression of a 172Arg→Leu mutant p53 in the mammary gland of transgenic mice results in altered lobuloalveolar development. Cell Growth Differ., 5: 711-721, 1994.
13. Kawasaki, E. Amplification of RNA. In: M. Innis, D. Gelfand, J. Sninsky, and T. White (eds.), PCR Protocols, pp. 21-27. New York: Academic Press, 1990.
14. Zalvide, J., and DeCaprio, J. A. Role of pRB-related proteins in simian virus 40 large-T-antigen-mediated transformation. Mol. Cell. Biol., 15: 5800-5810, 1995.
15. Isaacs, W., Bova, G., Morton, R., Bussemakers, M., Brooks, J., and Ewing, C. Molecular biology of prostate cancer progression. Cancer Surv., 23: 19-32, 1995.
16. Levine, A., Momand, J., and Finlay, C. The p53 tumour suppressor gene. Nature (Lond.), 351: 453-456, 1991.
17. Ewald, D., Li, M., Efrat, S., Auer, G., Wall, R. J., Furth, P. A., and Hennighausen, L. Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science (Washington DC), 273: 1384-1386, 1996.
18. Sepulveda, A., Finegold, M., Smith, B., Slagle, B., DeMayo, J., Shen, R., Woo, S., and Butel, J. Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression ot SV40 large T-antigen controlled by regulatory elements of the human α-1-antitrypsin gene. Cancer Res., 49: 6108-6117, 1989.
19. Kwon, E. D., Hurwitz, A. A., Foster, B. A., Madias, C., Feldhaus, A. L., Greenberg, N. M., Burg, M. B., and Allison, J. P. Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer. Proc. Natl. Acad. Sci. USA, 94: 8099-8103, 1997.